Ensign Peak Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $431K | Hold |
9,139
| – | – | ﹤0.01% | 1594 |
|
|
2025
Q1 | $357K | Hold |
9,139
| – | – | ﹤0.01% | 1623 |
|
|
2024
Q4 | $495K | Sell |
9,139
-33,174
| -78% | -$1.8M | ﹤0.01% | 1597 |
|
|
2024
Q3 | $2.13M | Sell |
42,313
-10,874
| -20% | -$548K | ﹤0.01% | 916 |
|
|
2024
Q2 | $2.34M | Hold |
53,187
| – | – | ﹤0.01% | 848 |
|
|
2024
Q1 | $2.67M | Sell |
53,187
-461
| -0.9% | -$23.2K | ﹤0.01% | 818 |
|
|
2023
Q4 | $3.24M | Buy |
53,648
+44,048
| +459% | +$2.66M | 0.01% | 739 |
|
|
2023
Q3 | $547K | Buy |
+9,600
| New | +$547K | ﹤0.01% | 1563 |
|
|
2023
Q2 | – | Sell |
-11,575
| Closed | -$248K | – | 1768 |
|
|
2023
Q1 | $248K | Buy |
+11,575
| New | +$248K | ﹤0.01% | 1730 |
|